Why AC Immune Stock Zoomed Almost 15% Higher Today [Yahoo! Finance]
AC Immune SA (ACIU)
Last ac immune sa earnings: 11/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
acimmune.com/en/investors
Company Research
Source: Yahoo! Finance
The Switzerland-based biotech saw its stock zoom nearly 15% skyward on Tuesday, following news of a favorably revised collaboration agreement with a pharmaceutical sector titan within our borders. Fruitful partnership AC Immune, a clinical-stage biotech that develops precision medicine targeting neurodegenerative disorders, is currently in a partnership with Eli Lilly . The two companies have a license and collaboration agreement centered on AC Immune's Morphomer platform, from which it aims to develop next-generation treatments for Alzheimer's disease and other neurodegenerative afflictions. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Image source: Getty Images. The European company announced on Tuesday that the agreement, dating back to 2018, has been amended. Eli Lilly will pay AC Immune 10 million
Show less
Read more
Impact Snapshot
Event Time:
ACIU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACIU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACIU alerts
High impacting AC Immune SA news events
Weekly update
A roundup of the hottest topics
ACIU
News
- Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with LillyGlobeNewswire
- AC Immune FY 2025 Results: Eyeing ACI-7104 Catalysts [Seeking Alpha]Seeking Alpha
- AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026GlobeNewswire
- Is AC Immune (ACIU) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
ACIU
Earnings
- 3/13/26 - Miss
ACIU
Sec Filings
- 4/7/26 - Form 6-K
- 4/1/26 - Form 3
- 3/20/26 - Form 3
- ACIU's page on the SEC website